Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Journal of King Saud University - Science ; : 102109, 2022.
Article in English | ScienceDirect | ID: covidwho-1851571

ABSTRACT

Objectives Sandstorms are natural climate calamities causing severe weather changes and health problems. The sandstorm allied issues are of significant apprehension worldwide, mainly in the present pandemic. This study aims to examine the “sandstorm impact on environmental pollution particulate matter (PM2.5), carbon monoxide (CO), ozone (O3), and daily new cases and deaths due to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)” in Kuwait. Methods The two incidences of sandstorms occurred in Kuwait, dated 13 March 2021 and 13 June 2021. The data on “PM2.5, CO, NO2, and O3, and SARS-CoV-2 cases and deaths” were documented three weeks before and after both incidences of the sandstorm. For the first incidence, the data was recorded from 18 February to 12 March 2021;and from 13 March to 2 April 2021. However, for the second incidence of sandstorms, data were documented from 23 May to 12 June 2021;and from 13 June to 3 July 2021. The daily “PM2.5, CO, NO2, and O3levels” were recorded from “Air Quality Index-AQI, metrological web, and data on COVID-19 daily cases and deaths were recorded from the World Health Organization”. Results After the first and second sandstorm incidence, the air contaminants PM2.5 was increased by 26.62%, CO 22.08%, and O3 increased 18.10% compared to before the sandstorm. SARS-CoV-2 cases were markedly amplified by (21.25%), and deaths were increased by (61.32%) after the sandstorm. Conclusions Sandstorm events increase air pollutants PM2.5, CO, and O3levels, and these pollutants increase the SARS-COV-2 daily cases and deaths in Kuwait. The findings have a meaningful memorandum to healthcare representatives to advise the public about the health hazards of the sandstorm and its linkage with SARS-CoV-2 cases and deaths.

3.
biorxiv; 2020.
Preprint in English | bioRxiv | ID: ppzbmed-10.1101.2020.11.17.377432

ABSTRACT

Renessans is an iodine complex which has proven in vitro antiviral activity including Anti-SARS-CoV-2 activity. The present study was designed to determine its efficacy against SARS-CoV-2 in monkeys (Rhesus macaque). A total of 14 monkeys were divided into four groups: A) Prophylactic group (n=03), (B) Treatment group (n=03), (C) infection control group (n=04) and (D) negative control group (n=04) and were housed in BSL-3 Animal facility while group D was housed at another animal house. Group A was administered with Renessans @ 2.85 mg/7 kg from 5 days prior to the infection to 08 days post infections (DPI). Group B was administered with Renessans from 03-08 DPI @ 2.85 mg/7 kg. Group C was administered with WIF only. The infection @ 2 x 106 TCID of SARS-CoV-2 was given to all group monkeys through intranasal and oral route under anesthesia. Nasal swab samples (at different times) and fecal matter on daily basis were collected for the detection of SARS-CoV-2 through real-time quantitative PCR. Three monkeys (one from each of group A, B and C) were euthanized at 07 DPI to determine the gross pathological lesions and SARS-CoV-2 detection from internal tissues. Nasal swabs from all the monkeys from group A, B and C were positive for SARS-CoV-2 at 02 and 07 DPI (Day 05 of treatment). At 14 DPI, all (100%) nasal swabs from group A were negative for SARS-CoV-2 while 50% and 100% were positive from group B and C, respectively. At 21 DPI, monkeys from group B were negative and all in group C were still positive for SARS-CoV-2. Similarly, fecal matter of monkeys in group A and B was returned negative in significantly lesser time as compared to monkeys from infection control group. Based on these research findings it is concluded that the Renessans has in-vivo SARS-CoV-2 activity and may result in early clearance of SARS-CoV-2. Therefore, a clinical trial of the drug in COVID-19 patients may reveal its anti-COVID-19 potential.


Subject(s)
COVID-19
4.
biorxiv; 2020.
Preprint in English | bioRxiv | ID: ppzbmed-10.1101.2020.11.18.388983

ABSTRACT

Memory CD8+ T cells are associated with a better outcome in Coronavirus Disease 2019 (COVID-19) and recognized as promising vaccine targets against viral infections. This study determined the efficacy of population-dominant and infection-relevant human leukocyte antigens (HLA) class I proteins to present severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) peptides through calculating binding affinities and simulating CD8+ T cell responses. As a result, HLA class I proteins distinguished or shared various viral peptides derived from viruses. HLA class I supertypes clustered viral peptides through recognizing anchor and preferred residues. SARS-CoV-2 peptides overlapped significantly with SARS but minimally with common human coronaviruses. Immune simulation of CD8+ T cell activation using predicted SARS-CoV-2 peptide antigens depended on high-affinity peptide binding, anchor residue interaction, and synergistic presentation of HLA class I proteins in individuals. Results demonstrated that multi-epitope vaccination, employing a strong binding affinity, viral adjuvants, and heterozygous HLA class I genes, induced potent immune responses. Therefore, optimal CD8+ T cell responses can be achieved and customized contingent on HLA class I genotypes in human populations, supporting a precise vaccination strategy to combat COVID-19.


Subject(s)
COVID-19 , Severe Acute Respiratory Syndrome
5.
medrxiv; 2020.
Preprint in English | medRxiv | ID: ppzbmed-10.1101.2020.07.31.20165126

ABSTRACT

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections has affected more than 15 million people and, as of 22 July 2019, caused deaths of more than 0.6 million individuals globally. With the excretion of SARS-CoV-2 in the stool of symptomatic and asymptomatic COVID-19 patients, its genome detection in the sewage water can be used as a powerful epidemiological tool to predict the number of positive cases in a population. This study was conducted to detect SARS-CoV-2 genome in sewage water during the lockdown. Sewage samples, from 28 pre-selected sites, were collected on alternate days from 13-25 July, 2020 from two selected areas [Johar Town (n = 05) and Township (n = 23)], where smart lockdown were implemented by the government authorities on 9th July, 2020. Genomic RNA was extracted and the SARS-CoV-2 was detected and quantified using commercially available kit through Real-Time PCR. Out of 28, sixteen samples were positive on day one while 19, 17, 23, 17, 05 and 09 samples were positive on day 3, 5, 7, 9, 11, and 13, respectively. These results indicate the decreasing viral copy load with the passage of time however few sites did not followed a clear pattern indicating the complexities in sewage water based surveillance i.e time of sampling. Hourly sampling from two sites for 24 hours also revealed the impact of time sampling time on detection of SARS-CoV-2 genome in sewage pipelines and lift/disposal stations. Results of current study indicate a possible role of sewage-based COVID-19 surveillance in monitoring and execution of smart lockdowns.


Subject(s)
Coronavirus Infections , COVID-19
SELECTION OF CITATIONS
SEARCH DETAIL